PPT-What do we know about cannabis

and synthetic cannabinoids Spice Miriam Komaromy MD Associate Director ECHO Institute miriamk1saludunmedu overview Cannabis Epidemiology Effects Risks Cannabis Use Disorder. YOUR NAME. Chapter Chairwoman. #. womengrow. CONNECT. EDUCATE. EMPOWER. Women Will Lead Cannabis Purchasing. Women make more than 80% of healthcare purchasing . decisions. Women account for 93% OTC pharmaceutical . Talking to your doctor, Safety and Update on Clinical Trials. Lubov. . Romantseva. , MD. Child Neurology and Epilepsy. Rush University Medical Center. Nov 12, 2016. Disclosures. I have no financial interest in any pharmaceutical company mentioned in this presentation. An agricultural crop…. Division 4, Agriculture. Section W. Worker Protection Standard. Section Z. Hazard Communication. Section . I. Protective Equip. (Respiratory . Protection). Section . N. Material Handling. Professor Jennifer H. Martin . MBChB. , FRACP, PhD. Chair, Clinical Pharmacology. Uni. of Newcastle, Australia. Overview. Need for evidence . Where there is evidence. Challenges of cannabis research . By: Phyliss Nicole Taylor, MD . Medical Director, Assistant Professor . UF Health Psychiatry . Financial Disclosures . None . Objectives. Understand what Amendment 2 means for FL physicians and patients. . Presented by: Candice Beathard, PhD. December 15, 2015 . Background. 23 States and D.C. have enacted medical cannabis programs. 1. . 1. Marijuana Policy Project, 2015. . Background. State programs specify list of qualifying conditions. drug control . system and its effects on science. Tom Blickman– TNI. tblick@tni.org. The Rise and Decline of Cannabis Prohibition. The . History of Cannabis in the UN Drug Control System and Options For Reform. RDNs: Get Up to Speed about Cannabis!. Denver Dietetic Association. November 9, 2017. . Donna Shields. , . MS, RDN. Co-Founder. , . Holistic Cannabis Academy. donna@holisticcannabisacademy.com. 305.967.1600. Erik Messamore, MD, PhD. Associate Professor of Psychiatry, Northeast Ohio Medical University. Medical Director, Best Practices for Schizophrenia Treatment (BeST) Center. Overview. Cannabis association with acute psychosis is well-known. The Cole Memo – August 2013. Distribution to minors. Revenue going to criminals. Going to states where it is not legal. Used as a cover for trafficking of other illegal drugs/activity. Violence and use of guns in cultivation and distribution. Learning Objectives . Review the New Mexico Cannabis Program.. Describe how cannabis works in the body.. Identify available dosage forms and their benefits and cautions. . Identify common adverse effects of medical cannabis use.. What are the effects of the current cannabis policy? . How is cannabis policy changing in other states?. What technical elements need to be addressed? . What goals should Minnesota have for legalizing adult-use cannabis?. The Role of Potency in Cannabis Use Outcomes. A joint report from the University of Washington . and Washington State University Workgroup . for the Prevention and Research Sub Committee (PRSC) . October 2020. Kelay Trentham, MS, RDN, CSO, FAND . Oncology Dietitian. MultiCare. Regional Cancer Center. Tacoma, WA. What we’ll talk about today. History of medical cannabis use. Does it work? If so, for what?.